FeelGood vs MEDVi: Which GLP-1 Provider Is Better?
Short answer: FeelGood scores higher on our rubric, 7.0/10 against 5.7/10. Full reasoning, pricing and the cases where the other one wins are below.
FeelGood beats MEDVi overall, scoring 7/10 vs 5.7/10. Published pricing is not a like-for-like monthly comparison: FeelGood is from $149/mo; MEDVi is $179 first month, then $299/mo. Choose FeelGood for budget-conscious cash-pay patients who want low-cost compounded semaglutide, injection or oral tablet, with free shipping, no membership fees, and a money-back weight-loss guarantee. Choose MEDVi for users who want both oral and injectable compounded options in one telehealth program.
A side-by-side look at FeelGood and MEDVi to help you decide. We compare them on:
- •Starting price per month
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
FeelGood
#38 of 53Telehealth platform offering compounded semaglutide as both a weekly injection ($149/mo starting) and a daily oral tablet ($249/mo starting), plus a premium brand-name 'original' semaglutide injection option ($1,999/mo). Cash-pay only, no insurance billing, HSA/FSA eligible. LegitScript-approved. FeelGood does not publicly disclose which states it serves, its compounding pharmacy, or its medical leadership.
Visit FeelGoodMEDVi
#44 of 53MEDVi offers oral and injectable compounded GLP-1 care. Semaglutide is $179 for month one and $299 for refills. Trustpilot is 4.4/5 across roughly 11,000 reviews, while BBB is F/not accredited. FDA warning letter #721455 concerns misleading labeling and marketing, not an allegation that the medication was unsafe.
Visit MEDVi| Feature | FeelGood | MEDVi |
|---|---|---|
| Why each one | One of the cheapest compounded-semaglutide entry points ($149/mo) that ALSO offers an oral tablet route and a money-back weight-loss guarantee, backed by LegitScript approval, a combination uncommon at the budget end of the market. | Oral and injectable compounded formats in one program, with micro-dosing options and a path to FDA-approved brand medication. |
| Our Score | 7/10 | 5.7/10 |
| Headline Price | from $149/mo | $179 first month, then $299/mo |
| Medication Type | Both | Both |
| Insurance Accepted | No | No |
| Best For | Budget-conscious cash-pay patients who want low-cost compounded semaglutide, injection or oral tablet, with free shipping, no membership fees, and a money-back weight-loss guarantee | Users who want both oral and injectable compounded options in one telehealth program |
| Watch out for | Does NOT publicly disclose which US states it serves, you can't confirm availability in your state before starting an intake | FDA warning letter #721455, issued February 20, 2026, cites misleading labeling and marketing that implied MEDVi compounded the drugs and that compounded products were equivalent to or FDA-evaluated like approved brands. The letter does not allege unsafe medication |
| Ranking | #38 | #44 |
| Get started | Visit FeelGood | Visit MEDVi |
Pros & Cons Compared
FeelGood
Pros
- +Compounded semaglutide injection from $149/mo with free shipping and no separate membership or consultation fee
- +Offers an oral compounded semaglutide tablet ($249/mo) for needle-averse patients, a non-injectable route only a handful of platforms provide
- +LegitScript-approved, independent certification that the telehealth/pharmacy operation meets legal and safety standards, which many budget compounded shops lack
- +Money-back weight-loss guarantee plus unlimited 24/7 messaging and appointments included
Cons
- −Does NOT publicly disclose which US states it serves, you can't confirm availability in your state before starting an intake
- −$149 is a 'starting' price (dose-escalating), not flat across all doses, your cost can rise as your dose titrates up, and FeelGood doesn't publish the full dose-by-dose schedule
- −Brand-name 'original' semaglutide injection at $1,999/mo is far above NovoCare's Wegovy pen $199/mo for the first two 0.25 mg or 0.5 mg fills through December 31, 2026, then $349/mo at standard strengths or $399/mo for Wegovy HD; oral pill from $149/mo, dose-dependent, and Hims/Hers pill medication from $149 or pen from $199 plus required membership. Never buy brand-name through FeelGood
- −No named medical director, prescribing physicians, compounding pharmacy, founding year, or headquarters disclosed on the site, thin corporate and clinical transparency
- −Self-reported '4.8/5' rating is not tied to a named third-party platform (no linked Trustpilot/BBB), so it can't be independently verified; the advertised '15-20% weight loss' figures are FeelGood's marketing, not FDA-reviewed efficacy data
- −Compounded GLP-1s are not FDA-approved (none are), and FeelGood offers compounded semaglutide only, no tirzepatide
MEDVi
Pros
- +One of the few compounded providers offering both oral tablets and injectable semaglutide
- +Micro-dosing options available, can start at sub-standard doses for patients concerned about side effects
- +Sleek onboarding experience with clear progress tracking through their patient portal
- +$179 covers the first month of compounded semaglutide on the current Katalys landing, including clinician review, medication and shipping
Cons
- −FDA warning letter #721455, issued February 20, 2026, cites misleading labeling and marketing that implied MEDVi compounded the drugs and that compounded products were equivalent to or FDA-evaluated like approved brands. The letter does not allege unsafe medication
- −Its third-party records conflict: 4.4/5 across roughly 11,000 Trustpilot reviews, but an F and no accreditation at the BBB
- −The $179 semaglutide price is introductory; the current Katalys landing says refills are $299/mo, making the first-year total $3,468 rather than $2,148
- −Brand-name Wegovy and Zepbound paths add a $99 membership plus the medication cost, which the current landing does not publish; availability can change
- −No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms
Our Verdict
FeelGood edges out MEDVi with a score of 7/10 vs 5.7/10. Published pricing is not a like-for-like monthly comparison: FeelGood is from $149/mo; MEDVi is $179 first month, then $299/mo.
Cheapest complete recurring price in our index
Eden Health GLP-1
$99/mo month-to-month, from $34 on a plan · 6.9/10 · Both
Both FeelGood and MEDVi start above the cheapest complete recurring program we track. Across all 53 providers in our index, the lowest price with affirmative medication, consultation, and shipping inclusion is Eden Health GLP-1 at $99/mo, price checked August 28, 2026. It scores 6.9/10 and is not the highest-scored provider in our full rankings, so this is a cost floor rather than a recommendation. Worth knowing before you decide.
Read Full Reviews
Related comparisons
More head-to-head comparisons involving FeelGood and MEDVi.
Not comparing, just asking? Quick answers to the most-asked GLP-1 questions →
- Compare FeelGood and Direct Meds GLP-1from $297/mo
- Compare FeelGood and Maximuspublished $79.99/mo; total not verified
- Compare FeelGood and Embodyfrom $69/mo
- Compare MEDVi and MangoRxfrom $299/mo
- Compare MEDVi and HealthRXfrom $99/mo
- Compare MEDVi and Fella Health$299/mo month-to-month
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.
Still working out whether either one is above board? We check that separately: is MEDVi legit, with the verification evidence behind each answer.
Our pick of these two: FeelGood · 7.0/10